Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Macrogenics (MGNX) over the last 14 years, with Q3 2025 value amounting to $2.5 million.

  • Macrogenics' Other Working Capital Changes rose 59412.92% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$13.0 million, marking a year-over-year decrease of 22250.87%. This contributed to the annual value of -$9.4 million for FY2024, which is 18239.1% down from last year.
  • Per Macrogenics' latest filing, its Other Working Capital Changes stood at $2.5 million for Q3 2025, which was up 59412.92% from -$4.7 million recorded in Q2 2025.
  • In the past 5 years, Macrogenics' Other Working Capital Changes ranged from a high of $60.7 million in Q4 2022 and a low of -$19.9 million during Q2 2022
  • Its 5-year average for Other Working Capital Changes is $2.9 million, with a median of -$2.0 million in 2023.
  • Its Other Working Capital Changes has fluctuated over the past 5 years, first surged by 157017.77% in 2021, then plummeted by 164635.76% in 2025.
  • Macrogenics' Other Working Capital Changes (Quarter) stood at -$5.2 million in 2021, then skyrocketed by 1258.1% to $60.7 million in 2022, then tumbled by 103.21% to -$2.0 million in 2023, then crashed by 275.9% to -$7.3 million in 2024, then skyrocketed by 134.45% to $2.5 million in 2025.
  • Its Other Working Capital Changes stands at $2.5 million for Q3 2025, versus -$4.7 million for Q2 2025 and -$3.5 million for Q1 2025.